Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (Diclofenac Sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis
Status: Enrolling
Updated:  12/31/1969
Sirius Clinical Research, LLC
mi
from
Austin, TX
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (Diclofenac Sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis
Status: Enrolling
Updated: 12/31/1969
Sirius Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (Diclofenac Sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis
Status: Enrolling
Updated:  12/31/1969
Health Research of Hampton Roads
mi
from
Newport News, VA
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (Diclofenac Sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis
Status: Enrolling
Updated: 12/31/1969
Health Research of Hampton Roads
mi
from
Newport News, VA
Click here to add this to my saved trials
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Smith, AR
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Site 4814
mi
from
Czestochowa,
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Site 4814
mi
from
Czestochowa,
Click here to add this to my saved trials
Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
A Prospective, Open Label Trial of High Dose UVA-1, 3x/Week or Medium Dose UVA-1, 3x/Week vs. Fluocinonide 0.05% Cream Treatment of Morphea
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center at Dallas - Department of Dermatology Clinical Trials
mi
from
Dallas, TX
Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
A Prospective, Open Label Trial of High Dose UVA-1, 3x/Week or Medium Dose UVA-1, 3x/Week vs. Fluocinonide 0.05% Cream Treatment of Morphea
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center at Dallas - Department of Dermatology Clinical Trials
mi
from
Dallas, TX
Click here to add this to my saved trials
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated:  12/31/1969
Premier Plastic Surgery
mi
from
San Mateo, CA
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated: 12/31/1969
Premier Plastic Surgery
mi
from
San Mateo, CA
Click here to add this to my saved trials
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated:  12/31/1969
Skin Care Physicians
mi
from
Chestnut Hill, MA
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated: 12/31/1969
Skin Care Physicians
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated:  12/31/1969
Zel Skin and Laser Specialists
mi
from
Edina, MN
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated: 12/31/1969
Zel Skin and Laser Specialists
mi
from
Edina, MN
Click here to add this to my saved trials
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated:  12/31/1969
Laser & Dermatologic Surgery Center
mi
from
Chesterfield, MO
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Evaluation of Nano-Pulse Stimulation (NPS) in Patients With Seborrheic Keratosis
Status: Enrolling
Updated: 12/31/1969
Laser & Dermatologic Surgery Center
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Human Repeated Insult Patch Test
Human Repeated Insult Patch Test
Status: Enrolling
Updated:  12/31/1969
Consumer Product Testing Company
mi
from
Fairfield, NJ
Human Repeated Insult Patch Test
Human Repeated Insult Patch Test
Status: Enrolling
Updated: 12/31/1969
Consumer Product Testing Company
mi
from
Fairfield, NJ
Click here to add this to my saved trials
NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test
Skin Prick Test in Healthy Volunteers of Any Sex, to Investigate the Potential Allergy to NeoMatriXTM Wound Matrix
Status: Enrolling
Updated:  12/31/1969
University of Buffalo Clinical and Translational research Center
mi
from
Buffalo, NY
NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test
Skin Prick Test in Healthy Volunteers of Any Sex, to Investigate the Potential Allergy to NeoMatriXTM Wound Matrix
Status: Enrolling
Updated: 12/31/1969
University of Buffalo Clinical and Translational research Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dermatology and Laser Surgery
mi
from
Sacramento, CA
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dermatology and Laser Surgery
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
DermResearch, PLLC
mi
from
Louisville, KY
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
James Q. DelRosso DO, LLC
mi
from
Las Vegas, NV
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
James Q. DelRosso DO, LLC
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids
A Two Part Study: An Investigator-initiated, Single-center, Single-blinded, Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids
Status: Enrolling
Updated:  12/31/1969
Skin Research Group Office
mi
from
Miami, FL
A Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids
A Two Part Study: An Investigator-initiated, Single-center, Single-blinded, Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids
Status: Enrolling
Updated: 12/31/1969
Skin Research Group Office
mi
from
Miami, FL
Click here to add this to my saved trials
Effects of Pimecrolimus on Skin Biopsy Ex-Plants From Patients With Atopic Dermatitis
A Pilot Ex-Vivo Study to Evaluate the Effect of Pimecrolimus on Antimicrobial Peptide Expression and Vaccinia Virus Growth in Perilesional Skin Cultures of Patients With Atopic Dermatitis
Status: Enrolling
Updated:  9/20/2006
National Jewish Medical and Research Center
mi
from
Denver, CO
Effects of Pimecrolimus on Skin Biopsy Ex-Plants From Patients With Atopic Dermatitis
A Pilot Ex-Vivo Study to Evaluate the Effect of Pimecrolimus on Antimicrobial Peptide Expression and Vaccinia Virus Growth in Perilesional Skin Cultures of Patients With Atopic Dermatitis
Status: Enrolling
Updated: 9/20/2006
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
A Double-Blind, Parallel-Group Trial of Topical Pimecrolimus Cream 1% (Elidel®) Versus Clobetasol 0.05% Cream for the Treatment of Vulvar Lichen Sclerosus
Status: Enrolling
Updated:  10/26/2006
The Center for Vulvovaginal Disorders
mi
from
Washington,
Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
A Double-Blind, Parallel-Group Trial of Topical Pimecrolimus Cream 1% (Elidel®) Versus Clobetasol 0.05% Cream for the Treatment of Vulvar Lichen Sclerosus
Status: Enrolling
Updated: 10/26/2006
The Center for Vulvovaginal Disorders
mi
from
Washington,
Click here to add this to my saved trials
Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease
Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease
Status: Enrolling
Updated:  6/27/2007
St Francis Hospital
mi
from
Hartford, CT
Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease
Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease
Status: Enrolling
Updated: 6/27/2007
St Francis Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails
Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial
Status: Enrolling
Updated:  3/18/2008
Scholl Foot and Ankle Center
mi
from
North Chicago, IL
Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails
Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial
Status: Enrolling
Updated: 3/18/2008
Scholl Foot and Ankle Center
mi
from
North Chicago, IL
Click here to add this to my saved trials
Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails
Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial
Status: Enrolling
Updated:  3/18/2008
Preofessional Education and Research Institutue
mi
from
Roanoke, VA
Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails
Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial
Status: Enrolling
Updated: 3/18/2008
Preofessional Education and Research Institutue
mi
from
Roanoke, VA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  10/14/2008
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 10/14/2008
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated:  12/2/2008
University of Arizona
mi
from
Tucson, AZ
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated:  12/2/2008
Univ of Pennsylvania
mi
from
Philadelphia, PA
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Eczema Prevention Study
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
Status: Enrolling
Updated:  12/9/2008
Oregon Health & Science University, Department of Dermatology
mi
from
Portland, OR
Eczema Prevention Study
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
Status: Enrolling
Updated: 12/9/2008
Oregon Health & Science University, Department of Dermatology
mi
from
Portland, OR
Click here to add this to my saved trials
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated:  2/10/2009
Fichte,Endl, & Elmer EyeCare
mi
from
Amherst, NY
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated: 2/10/2009
Fichte,Endl, & Elmer EyeCare
mi
from
Amherst, NY
Click here to add this to my saved trials
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated:  2/10/2009
The Ira G. Ross Eye Institute
mi
from
Buffalo, NY
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated: 2/10/2009
The Ira G. Ross Eye Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
An Observational, Long-Term Follow-up Study of Eligible Individuals Declining To Participate in the Scleroderma Cyclophosphamide or Transplantation (SCOT) Study
Status: Enrolling
Updated:  3/26/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
An Observational, Long-Term Follow-up Study of Eligible Individuals Declining To Participate in the Scleroderma Cyclophosphamide or Transplantation (SCOT) Study
Status: Enrolling
Updated: 3/26/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
City of Hope National Medical Center
mi
from
Duarte, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
UCLA Medical School
mi
from
Los Angeles, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
UCLA Medical School
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
Boston University School of Medicine
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
University of Michigan
mi
from
Ann Arbor, MI
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
Duke University
mi
from
Durham, NC
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated:  3/27/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 02
Mechanistic Study: Vascular Cells and the Pathogenesis od Systemic Sclerosis
Status: Enrolling
Updated: 3/27/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
City of Hope National Medical Center
mi
from
Duarte, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
UCLA Medical School
mi
from
Los Angeles, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
UCLA Medical School
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
Boston University School of Medicine
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
University of Michigan
mi
from
Ann Arbor, MI
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
Duke University
mi
from
Durham, NC
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis
A 4 Week Randomized Double-Blind Parallel Group Active Comparator Controlled Study of Elidel for the Treatment of Seborrheic Dermatitis
Status: Enrolling
Updated:  3/31/2009
Dermatology Specialists
mi
from
Louisville, KY
A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis
A 4 Week Randomized Double-Blind Parallel Group Active Comparator Controlled Study of Elidel for the Treatment of Seborrheic Dermatitis
Status: Enrolling
Updated: 3/31/2009
Dermatology Specialists
mi
from
Louisville, KY
Click here to add this to my saved trials
Azelaic Acid Versus Hydroquinone in Melasma
Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma
Status: Enrolling
Updated:  6/24/2009
Callender Center for Clinical Research
mi
from
Mitchellville, MD
Azelaic Acid Versus Hydroquinone in Melasma
Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma
Status: Enrolling
Updated: 6/24/2009
Callender Center for Clinical Research
mi
from
Mitchellville, MD
Click here to add this to my saved trials
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
Status: Enrolling
Updated:  1/19/2010
Wright State University School of Medicine, Department of Dermatology
mi
from
Dayton, OH
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
Status: Enrolling
Updated: 1/19/2010
Wright State University School of Medicine, Department of Dermatology
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis
Transepidermal Water Loss (TEWL) and Corneometry With Hydrogel Vehicle in the Treatment of Atopic Dermatitis - A Randomized, Investigator-Blind Pilot Study
Status: Enrolling
Updated:  2/8/2010
DermResearch, PLLC
mi
from
Louisville, KY
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis
Transepidermal Water Loss (TEWL) and Corneometry With Hydrogel Vehicle in the Treatment of Atopic Dermatitis - A Randomized, Investigator-Blind Pilot Study
Status: Enrolling
Updated: 2/8/2010
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
Status: Enrolling
Updated:  3/5/2010
Department of Dermatology, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"
Status: Enrolling
Updated: 3/5/2010
Department of Dermatology, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials